Polarean INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersDurham, NC
SAM.gov UEIFSULLJ5XFVF1
Polarean develops Xenon MRI technology for lung imaging that measures regional lung function during a brief breath-hold, serving patients with chronic lung diseases including idiopathic pulmonary fibrosis, COPD, pulmonary hypertension, cystic fibrosis, and asthma. The company's Xenon MRI platform uses xenon signal rather than the hydrogen signal used in traditional MRI. The technology has FDA approval.
Summarized from the company’s own website
What they make
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Polarean INC | Durham | NC | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.